window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-113618785-2');

Partner in the Spotlight

HalioDx Immunoscore® identifies candidates for Phase II Colorectal Cancer Trial

2020-09-17T09:47:14+00:00September 16th, 2020|

We report more exciting news about the Immunoscore® diagnostic tool developed by our partners at HalioDx! The immuno-oncology diagnostic company, HalioDx announced last week that it has entered into a Collaboration Agreement with the FFCD, the French Cooperative Group dedicated exclusively to digestive oncology, on the Phase II multi-center POCHI trial (FFCD1703 - NCT04262687) in which [...]

Partner in the Spotlight: Halio Dx

2020-05-12T10:12:31+00:00May 12th, 2020|

This month we feature our partners at HalioDx. HalioDx ( is the pioneer of immuno-oncology diagnostic, a transforming approach of cancer care that benefits from novel and deep understanding of the tumour immune microenvironment. The company provides a unique and extensive range of proprietary assays that allow it to extract from the immune contexture of [...]

Go to Top